Profit Or Loss [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profit or loss [abstract] | ||||||||||
| Profit (loss) [abstract] | ||||||||||
| Revenue | — |
487,643,000
EUR
|
— | — | — | — |
504,477,000
EUR
|
— | — | — |
| Raw materials and consumables used | — |
336,017,000
EUR
|
— | — | — | — |
324,477,000
EUR
|
— | — | — |
| Employee benefits expense | — |
87,059,000
EUR
|
— | — | — | — |
68,511,000
EUR
|
— | — | — |
| Profit (loss) from operating activities | — |
30,496,000
EUR
|
— | — | — | — |
41,859,000
EUR
|
— | — | — |
| Finance income | — |
34,000
EUR
|
— | — | — | — |
21,000
EUR
|
— | — | — |
| Finance costs | — |
5,062,000
EUR
|
— | — | — | — |
3,398,000
EUR
|
— | — | — |
| Impairment loss (impairment gain and reversal of impairment loss) determined in accordance with IFRS 9 | — |
12,000
EUR
|
— | — | — | — |
74,000
EUR
|
— | — | — |
| Profit (loss) before tax | — |
35,524,000
EUR
|
— | — | — | — |
38,482,000
EUR
|
— | — | — |
| Tax expense (income) | — |
8,510,000
EUR
|
— | — | — | — |
8,798,000
EUR
|
— | — | — |
| Profit (loss) |
—
EUR
|
27,014,000
EUR
|
—
EUR
|
27,014,000
EUR
|
—
EUR
|
—
EUR
|
29,684,000
EUR
|
29,684,000
EUR
|
—
EUR
|
—
EUR
|
| Earnings per share [text block] | — | — | — | — | — | — | — | — | — | — |
| Earnings per share [abstract] | ||||||||||
| Earnings per share [line items] | ||||||||||
| Basic earnings per share [abstract] | ||||||||||
| Basic earnings (loss) per share | — |
1.24
|
— | — | — | — |
1.37
|
— | — | — |
| Diluted earnings per share [abstract] | ||||||||||
| Diluted earnings (loss) per share | — |
1.24
|
— | — | — | — |
1.36
|
— | — | — |